Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Adendra Therapeutics

Request full access

Adendra is an emerging biotechnology company building on new insights into dendritic cell biology to discover and develop new small molecule and biologic medicines for the treatment of a wide range of…

North Mymms, United KingdomFounded 2021Biotech & Life Sciences

About Adendra Therapeutics

Adendra Therapeutics is a cutting-edge biotechnology startup focused on developing innovative immunotherapies for treating solid tumors and autoimmune diseases. The company leverages the latest scientific insights into dendritic cell biology to create new treatments that can potentially transform the landscape of cancer and autoimmune disease therapy.

Adendra Therapeutics primarily serves patients suffering from cancer and autoimmune conditions, as well as healthcare providers and research institutions looking for advanced treatment options. The company operates in the highly specialized and competitive biotechnology and life sciences market, which is characterized by rapid innovation and significant investment in research and development.

The business model of Adendra Therapeutics revolves around the discovery and development of novel small molecules and biologic medicines. These are specialized drugs designed to target specific aspects of the immune system, particularly dendritic cells, which play a crucial role in initiating and regulating immune responses. By focusing on these cells, Adendra aims to develop therapies that can more effectively combat diseases with fewer side effects compared to traditional treatments.

Adendra Therapeutics generates revenue through a combination of research grants, partnerships with pharmaceutical companies, and potential future sales of its proprietary therapies. The company may also engage in licensing agreements, where it allows other companies to use its technology in exchange for royalties or upfront payments.

In summary, Adendra Therapeutics is at the forefront of developing next-generation immunotherapies by harnessing the power of dendritic cell biology. The company's innovative approach holds promise for creating more effective treatments for cancer and autoimmune diseases, offering hope to patients and healthcare providers alike.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
North Mymms, United Kingdom
Employees
3
Open positions
None listed
Dealroom signal
56.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, uk is8 life sciences, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Dec 2021 $53M $212M Apple Tree Partners ↗
SPINOUTOther financing Jan 2021 $0 — The Francis Crick Institute —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Adendra Therapeutics website traffic

Latest recorded traffic for Adendra Therapeutics is 2.7K monthly website visits, up 285.7% over the last three months. Adendra Therapeutics's team grew 0% over the past year.

Latest monthly visits2.7K 3-month web change+285.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Adendra Therapeutics in the North Mymms ecosystem

Live from Dealroom

The Adendra Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Apple Tree Partners

Other known investors1 additional known investor

  • The Francis Crick Institute
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇬🇧 United Kingdom100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Adendra Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Adendra Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.